Centene Corporation (CNC)
NYSE: CNC · Real-Time Price · USD
36.11
+1.61 (4.67%)
At close: Nov 4, 2025, 4:00 PM EST
36.10
-0.01 (-0.03%)
Pre-market: Nov 5, 2025, 5:52 AM EST
Centene Market Cap
Centene has a market cap or net worth of $17.75 billion as of November 5, 2025. Its market cap has decreased by -46.44% in one year.
Market Cap
17.75B
Enterprise Value
18.27B
1-Year Change
-46.44%
Ranking
Category
Stock Price
$36.11
Market Cap Chart
Since December 13, 2001, Centene's market cap has increased from $173.20M to $17.75B, an increase of 10,147.53%. That is a compound annual growth rate of 21.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 16.96B | -44.56% |
| Dec 31, 2024 | 30.58B | -22.85% |
| Dec 29, 2023 | 39.64B | -14.63% |
| Dec 30, 2022 | 46.44B | -3.41% |
| Dec 31, 2021 | 48.08B | 38.14% |
| Dec 31, 2020 | 34.81B | 33.79% |
| Dec 31, 2019 | 26.02B | 9.87% |
| Dec 31, 2018 | 23.68B | 36.01% |
| Dec 29, 2017 | 17.41B | 80.27% |
| Dec 30, 2016 | 9.66B | 23.10% |
| Dec 31, 2015 | 7.84B | 28.76% |
| Dec 31, 2014 | 6.09B | 88.70% |
| Dec 31, 2013 | 3.23B | 52.51% |
| Dec 31, 2012 | 2.12B | 6.14% |
| Dec 30, 2011 | 1.99B | 52.18% |
| Dec 31, 2010 | 1.31B | 36.35% |
| Dec 31, 2009 | 961.30M | 13.67% |
| Dec 31, 2008 | 845.70M | -29.19% |
| Dec 31, 2007 | 1.19B | 12.60% |
| Dec 29, 2006 | 1.06B | -5.45% |
| Dec 30, 2005 | 1.12B | -3.60% |
| Dec 31, 2004 | 1.16B | 107.10% |
| Dec 31, 2003 | 561.90M | 55.35% |
| Dec 31, 2002 | 361.70M | 63.67% |
| Dec 31, 2001 | 221.00M | 27.60% |
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.38B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |